Creative Biolabs: A Leading Supplier of Testing Services for Complement Research

September 13 22:24 2023
Drawing upon the decision to advance complement therapeutic discovery and development, Creative Biolabs launches a suite of testing services to accelerate clients’ projects.

New York, USA – September 13, 2023 – In recent years, there have been remarkable advancements in the field of complement testing, aimed at enhancing the understanding of disease severity and advancing the development of targeted therapies focused on the complement system. Creative Biolabs has emerged as a pioneering leader with a wealth of expertise in complement testing. The company’s commitment is to furnish clients with a comprehensive suite of testing services, encompassing complement activity assay, complement inhibitor evaluation, C3 functional tests, and complement activation products tests. These services are pivotal in meeting the urgent need for research and therapy development for diseases associated with complement dysregulation.

According to a scientist at Creative Biolabs, “the total complement activity test gives us a deep understanding of how active the complement system is. It’s a really handy tool for creating treatments that focus on the complement system.”

“We provide diverse testing services to help clients measure the effect of complement inhibitors,” added the scientist. “Over the last several years, we have completed hundreds of complement testing projects and expedited their project progression, providing dependable and effective testing data and results.”

Among these, complement inhibitor evaluation is an essential testing part that has a significant impact on the identification of potential complement inhibitors. At Creative Biolabs, scientists adopt diverse approaches to make verification, including hemolytic inhibition assays, cell imaging-based high-throughput screening, receptor-ligand binding assays, and quantitative chromogenic assays. Also, it is available to design custom solutions for complement inhibitor validation, advancing clients’ complement therapeutic research.

Furthermore, the company developed various specific monoclonal antibodies applied to complement activation product test. Testing services for multiple activation products of complement are available at Creative Biolabs, including C3 activation products, C4 activation products, Factor B activation products, and C1rs-C1 inhibitors. With extensive experience in complement testing, Creative Biolabs guarantees accurate results and high-quality testing service at an efficient pace.

Explore more testing services regarding complement therapeutic research at Creative Biolabs, please visit

About Creative Biolabs

Creative Biolabs, a world-leading biotechnology company based in the USA, is dedicated to providing testing and assay services to tackle scientific challenges in complement therapeutics research projects, including but not limited to complement activity assays, complement inhibitor evaluation, C3 functional testing, and complement activation products testing.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States